Evrysdi Approved in Europe as First Oral, At-home Treatment & The Evrysdi Chronicles

from The Spinal Muscular Atrophy Podcast with Kevin Schaefer · host SMA News Today

SMA News Today’s multimedia associate, Price Wooldridge, discusses Evrysdi’s approval in Europe as the first oral, at-home treatment for Spinal Muscular Atrophy (SMA).Also, DeAnn Runge reads the latest column from Brianna Albers as she continues the quest to start the SMA treatment Evrysdi, The Evrysdi Chronicles: Full Speed Ahead.Are you interested in learning more about spinal muscular atrophy? If so, please visit https://smanewstoday.com/

Episode metadata supplied by the publisher feed · Published Apr 12, 2021

Embed this episode

Attribution link and audio player

Ready to play

Evrysdi Approved in Europe as First Oral, At-home Treatment & The Evrysdi Chronicles

0:00 10:55

1×

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Share this episode

Similar Episodes

No similar episodes found.

Similar Podcasts

No similar podcasts found.

Frequently Asked Questions

How long is this episode of The Spinal Muscular Atrophy Podcast with Kevin Schaefer?

This episode is 10 minutes long.

When was this The Spinal Muscular Atrophy Podcast with Kevin Schaefer episode published?

This episode was published on April 12, 2021.

Can I download this The Spinal Muscular Atrophy Podcast with Kevin Schaefer episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.

URL copied to clipboard!